Scott Biller - Net Worth and Insider Trading
Scott Biller Net Worth
The estimated net worth of Scott Biller is at least $5 Million dollars as of 2024-11-13. Scott Biller is the Chief Scientific Officer of Agios Pharmaceuticals Inc and owns about 79,570 shares of Agios Pharmaceuticals Inc (AGIO) stock worth over $5 Million. Details can be seen in Scott Biller's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Scott Biller has not made any transactions after 2019-04-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Scott Biller
Scott Biller Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott Biller owns 2 companies in total, including Foghorn Therapeutics Inc (FHTX) , and Agios Pharmaceuticals Inc (AGIO) .
Click here to see the complete history of Scott Biller’s form 4 insider trades.
Insider Ownership Summary of Scott Biller
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FHTX | Foghorn Therapeutics Inc | 2020-10-22 | director |
| AGIO | Agios Pharmaceuticals Inc | 2019-04-05 | Chief Scientific Officer |
Scott Biller Latest Holdings Summary
Scott Biller currently owns a total of 1 stock. Scott Biller owns 79,570 shares of Agios Pharmaceuticals Inc (AGIO) as of April 5, 2019, with a value of $5 Million.
Latest Holdings of Scott Biller
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AGIO | Agios Pharmaceuticals Inc | 2019-04-05 | 79,570 | 59.01 | 4,695,426 |
Holding Weightings of Scott Biller
Scott Biller Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott Biller has made a total of 0 transactions in Agios Pharmaceuticals Inc (AGIO) over the past 5 years. The most-recent trade in Agios Pharmaceuticals Inc is the sale of 3,000 shares on April 5, 2019, which brought Scott Biller around $203,130.
Insider Trading History of Scott Biller
- 1
Scott Biller Trading Performance
Scott Biller Ownership Network
Ownership Network List of Scott Biller
Ownership Network Relation of Scott Biller
Scott Biller Owned Company Details
What does Foghorn Therapeutics Inc do?
Who are the key executives at Foghorn Therapeutics Inc?
Scott Biller is the director of Foghorn Therapeutics Inc. Other key executives at Foghorn Therapeutics Inc include Chief People Officer Carlos Costa , See Remarks Steven F. Bellon , and Chief Strategy/Bus Ops Officer Fanny Cavalie .
Foghorn Therapeutics Inc (FHTX) Insider Trades Summary
Over the past 18 months, Scott Biller made no insider transaction in Foghorn Therapeutics Inc (FHTX). Other recent insider transactions involving Foghorn Therapeutics Inc (FHTX) include a net sale of 58,859 shares made by Carlos Costa , a net sale of 311,297 shares made by Samuel Agresta , and a net sale of 20,000 shares made by Steven F. Bellon .
In summary, during the past 3 months, insiders sold 78,859 shares of Foghorn Therapeutics Inc (FHTX) in total and bought 0 shares, with a net sale of 78,859 shares. During the past 18 months, 401,156 shares of Foghorn Therapeutics Inc (FHTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 401,156 shares.
Foghorn Therapeutics Inc (FHTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Foghorn Therapeutics Inc Insider Transactions
Scott Biller Mailing Address
Above is the net worth, insider trading, and ownership report for Scott Biller. You might contact Scott Biller via mailing address: C/o Agios Pharmaceuticals, Inc., 38 Sidney Street, 2nd Floor, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
